Page 43 - Biennial Report 2018-20 Jun 2021
P. 43

are required not only to minimize the degradation and non-specific distribution of the cargoes
                  but also to maximize the therapeutic efficacy i.e. the delivery of the cargo at a specific site of
                  action thereby  minimizing side  effects. In  the last few  years, tremendous growth has been
                  recorded in  the development of biomaterials for the delivery of bioactive substances
                  (conventional drugs, proteins, nucleic acids, etc.). During this period, Dr. Pradeep Kumar’s group
                  was also  engaged in research activities  towards design, synthesis,  modifications and
                  characterization of polymeric and metallic nanoparticles showing these materials as safe and
                  efficient carriers for bioactive molecules with special emphasis on delivery of nucleic acids/drug
                  molecules. Recently, his group has developed some linear and branched polyethylenimine-based
                  cationic vectors for efficient transportation of genetic material across mammalian cells. In one
                  of such studies, linear polyethylenimine, a poor transfection reagent bearing secondary amines,
                  was conjugated with a variable amount of a ligand with a terminal boronic acid residue. The
                  resulting conjugates were characterized spectroscopically and shown to carry plasmid DNA more
                  efficiently than the native one. Enhanced uptake and internalization of the complexes were
                  found to be due to improved interactions of the complexes with the sialic acid expressed on the
                  surface of the cells, which facilitated endocytosis and transfection efficiency.

                  In another study, his group has demonstrated the importance of design and development of a
                  multifunctional carrier. Here, they have conjugated variable amounts of streptomycin, a broad-
                  spectrum antibacterial and  antimycobacterial aminoglycoside, to low  molecular  weight
                  branched polyethylenimine and degree of substitution determined. Transfection studies showed
                  that the series of conjugates transfected the mammalian cells efficiently (~9-fold enhancement
                  with respect to native bPEI) exhibiting high cell viability too. Besides, the series of conjugates
                  displayed  excellent  antibacterial activity  on pathogenic bacteria, even better than native
                  streptomycin on resistant strains. These results ensure the promising potential of the projected
                  multifunctional conjugates as safe and efficient gene delivery vectors as well as antibacterials for
                  future biomedical applications.

                  His group has also been working on the design and development of biocompatible nanomaterials
                  for drug  delivery using an approach of  molecular self-assembly. Use  of substituted
                  polysaccharides for such applications offers the ease of design and synthesis and provides higher
                  biofunctionality and biocompatibility to nanomaterials. In the present work, the group focuses
                  on the  synthesis,  characterization,  and  potential  biomedical  applications  of  self-assembled
                  polysaccharide-based  materials. They have demonstrated that the amphiphilic inulin self-
                  assembles in aqueous medium into nanostructures and encapsulates hydrophobic therapeutic
                  molecules, ornidazole.  Hydrophophic dehydropeptide conjugation via a biocompatible  ester
                  linkage makes it stable at a broader range of pH as well as against proteases. The resulting core-
                  shell type of nanostructures have been shown to encapsulate ornidazole in the hydrophobic core
                  and release it in a controlled fashion.

                  By taking the advantage of inulin, which gets degraded in the colon by colonic bacteria, the effect
                  of enzyme, inulinase, present in the microflora  of the large intestine, on inulin-peptide
                  degradation followed by drug release has also been studied. Altogether, the group claims that
                  the projected amphiphilic inulin offers novel scaffold for the future design of nanostructures
                  with potential applications in the field of targeted drug delivery.







                                                           42
   38   39   40   41   42   43   44   45   46   47   48